Researchers are warning that men who regularly dodge prostate cancer screening appointments are 45% more likely to die from the disease. Prostate cancer is the most common cancer among men and the ...

If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...

A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence, Swedish ...

For men aged 50-69 years who underwent a one-time prostate-specific antigen (PSA) screening for prostate cancer, a lower prostate cancer-specific mortality was observed after 15 years of follow-up, ...

Former President Biden recently revealed he has an aggressive form of prostate cancer that has spread to his bones. The news may have provoked concern in men with an enlarged prostate. But Dr. Pat ...